Kickstart your Whole Exome Sequencing research with IDT and Novogene
Are you looking for advanced, cost-effective solutions that can provide novel perspectives on diagnosis, intervention, and treatment of diseases? More than 85% of the gene variants that cause disease are harbored within the exome, which accounts for only ~1% of the entire Human Genome. Whole Exome Sequencing (WES) is the most practical way to detect and link disease-causing genetic variants to clinical pathology because it focuses only on the protein-coding exons. This targeted sequencing approach lowers the cost and time of sequencing. This webinar will provide a birds-eye view of the WES workflow at Novogene using IDT’s Advanced Exome Sequencing Kit (xGen Exome Hyb Panel V2). We will discuss sample requirements, the accuracy and capture efficiency of IDT’s exome capture kit, the sequencing approach, and our standard and advanced bioinformatic analysis packages. At the end of this webinar, you will have a deeper understanding of how IDT and Novogene’s WES products can facilitate and inspire your research goals in fields such as population genetics, genetic disease, and oncology.
- This webinar will show how Whole Exome Sequencing (WES) is a cost-effective, targeted sequencing approach to detecting disease-associated variants and its applications in pathology, oncology, and population genetics. You will understand how the capture efficiency and accuracy of IDT’s Exome Capture Kit is one of the most important factors for final sequencing data quality.